According to this study, the global Peptide CRO Services market size will reach US$ 900 million by 2031.
Peptide CRO services refer to integrated outsourced R&D services provided by professional third-party R&D institutions around peptide drugs or functional peptide products, covering the entire process of peptide sequence design, solid phase synthesis, liquid phase purification, structure identification, modification (such as PEGylation, cyclization), impurity research, formulation development and CMC registration support. With the widespread application of peptide drugs in the fields of tumors, metabolic diseases, vaccine adjuvants, etc., customers' demand for process development and pilot-scale expansion of high-purity, long-acting, and difficult-to-synthesize peptides continues to grow, which has promoted the rapid development of the peptide CRO service market. This type of service has the characteristics of high professional barriers, strong entry barriers, and strict equipment and compliance requirements. It is widely used in global new drug development and generic drug consistency evaluation projects.
United States market for Peptide CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Peptide CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Peptide CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Peptide CRO Services players cover Bachem AG, CPC Scientific, CSBio, Peptide Institute, AmbioPharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧eptide CRO Services Industry Forecast鈥� looks at past sales and reviews total world Peptide CRO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide CRO Services sales for 2025 through 2031. With Peptide CRO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide CRO Services industry.
This Insight Report provides a comprehensive analysis of the global Peptide CRO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide CRO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peptide CRO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide CRO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide CRO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide CRO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Linear Peptide Synthesis
Cyclic Peptide Synthesis
Modified Peptide Synthesis
Others
Segmentation by Application:
Pharmaceutical Companies
Biological Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem AG
CPC Scientific
CSBio
Peptide Institute
AmbioPharm
PeptiSystems
ABZENA PLC
Buchi
Aurigene Pharmaceutical Services
Syngene
Cusabio
Immunocure
Thermo Fisher
Svar Life Science
PolyPeptide
JYMed Technology
Peptites Biotech
Sun-Novo Pharmaceutical Research
Genevoyager
GenScript
Viva Biotech
Space Peptides Pharmaceutical
TriApex Laboratories
Go Top Peptide Biotech
IMED Bioscience
Motif Biotechnology
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Peptide CRO Services 麻豆原创 Size (2020-2031)
2.1.2 Peptide CRO Services 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Peptide CRO Services by Country/Region (2020, 2024 & 2031)
2.2 Peptide CRO Services Segment by Type
2.2.1 Linear Peptide Synthesis
2.2.2 Cyclic Peptide Synthesis
2.2.3 Modified Peptide Synthesis
2.2.4 Others
2.3 Peptide CRO Services 麻豆原创 Size by Type
2.3.1 Peptide CRO Services 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Peptide CRO Services 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Peptide CRO Services Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Biological Laboratories
2.4.3 Others
2.5 Peptide CRO Services 麻豆原创 Size by Application
2.5.1 Peptide CRO Services 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Peptide CRO Services 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Peptide CRO Services 麻豆原创 Size by Player
3.1 Peptide CRO Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Peptide CRO Services Revenue by Player (2020-2025)
3.1.2 Global Peptide CRO Services Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Peptide CRO Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide CRO Services by Region
4.1 Peptide CRO Services 麻豆原创 Size by Region (2020-2025)
4.2 Global Peptide CRO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide CRO Services 麻豆原创 Size Growth (2020-2025)
4.4 APAC Peptide CRO Services 麻豆原创 Size Growth (2020-2025)
4.5 Europe Peptide CRO Services 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Peptide CRO Services 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Peptide CRO Services 麻豆原创 Size by Country (2020-2025)
5.2 Americas Peptide CRO Services 麻豆原创 Size by Type (2020-2025)
5.3 Americas Peptide CRO Services 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide CRO Services 麻豆原创 Size by Region (2020-2025)
6.2 APAC Peptide CRO Services 麻豆原创 Size by Type (2020-2025)
6.3 APAC Peptide CRO Services 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide CRO Services 麻豆原创 Size by Country (2020-2025)
7.2 Europe Peptide CRO Services 麻豆原创 Size by Type (2020-2025)
7.3 Europe Peptide CRO Services 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide CRO Services by Region (2020-2025)
8.2 Middle East & Africa Peptide CRO Services 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Peptide CRO Services 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Peptide CRO Services 麻豆原创 Forecast
10.1 Global Peptide CRO Services Forecast by Region (2026-2031)
10.1.1 Global Peptide CRO Services Forecast by Region (2026-2031)
10.1.2 Americas Peptide CRO Services Forecast
10.1.3 APAC Peptide CRO Services Forecast
10.1.4 Europe Peptide CRO Services Forecast
10.1.5 Middle East & Africa Peptide CRO Services Forecast
10.2 Americas Peptide CRO Services Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Peptide CRO Services Forecast
10.2.2 Canada 麻豆原创 Peptide CRO Services Forecast
10.2.3 Mexico 麻豆原创 Peptide CRO Services Forecast
10.2.4 Brazil 麻豆原创 Peptide CRO Services Forecast
10.3 APAC Peptide CRO Services Forecast by Region (2026-2031)
10.3.1 China Peptide CRO Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Peptide CRO Services Forecast
10.3.3 Korea 麻豆原创 Peptide CRO Services Forecast
10.3.4 Southeast Asia 麻豆原创 Peptide CRO Services Forecast
10.3.5 India 麻豆原创 Peptide CRO Services Forecast
10.3.6 Australia 麻豆原创 Peptide CRO Services Forecast
10.4 Europe Peptide CRO Services Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Peptide CRO Services Forecast
10.4.2 France 麻豆原创 Peptide CRO Services Forecast
10.4.3 UK 麻豆原创 Peptide CRO Services Forecast
10.4.4 Italy 麻豆原创 Peptide CRO Services Forecast
10.4.5 Russia 麻豆原创 Peptide CRO Services Forecast
10.5 Middle East & Africa Peptide CRO Services Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Peptide CRO Services Forecast
10.5.2 South Africa 麻豆原创 Peptide CRO Services Forecast
10.5.3 Israel 麻豆原创 Peptide CRO Services Forecast
10.5.4 Turkey 麻豆原创 Peptide CRO Services Forecast
10.6 Global Peptide CRO Services Forecast by Type (2026-2031)
10.7 Global Peptide CRO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Peptide CRO Services Forecast
11 Key Players Analysis
11.1 Bachem AG
11.1.1 Bachem AG Company Information
11.1.2 Bachem AG Peptide CRO Services Product Offered
11.1.3 Bachem AG Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Bachem AG Main Business Overview
11.1.5 Bachem AG Latest Developments
11.2 CPC Scientific
11.2.1 CPC Scientific Company Information
11.2.2 CPC Scientific Peptide CRO Services Product Offered
11.2.3 CPC Scientific Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 CPC Scientific Main Business Overview
11.2.5 CPC Scientific Latest Developments
11.3 CSBio
11.3.1 CSBio Company Information
11.3.2 CSBio Peptide CRO Services Product Offered
11.3.3 CSBio Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 CSBio Main Business Overview
11.3.5 CSBio Latest Developments
11.4 Peptide Institute
11.4.1 Peptide Institute Company Information
11.4.2 Peptide Institute Peptide CRO Services Product Offered
11.4.3 Peptide Institute Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Peptide Institute Main Business Overview
11.4.5 Peptide Institute Latest Developments
11.5 AmbioPharm
11.5.1 AmbioPharm Company Information
11.5.2 AmbioPharm Peptide CRO Services Product Offered
11.5.3 AmbioPharm Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 AmbioPharm Main Business Overview
11.5.5 AmbioPharm Latest Developments
11.6 PeptiSystems
11.6.1 PeptiSystems Company Information
11.6.2 PeptiSystems Peptide CRO Services Product Offered
11.6.3 PeptiSystems Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 PeptiSystems Main Business Overview
11.6.5 PeptiSystems Latest Developments
11.7 ABZENA PLC
11.7.1 ABZENA PLC Company Information
11.7.2 ABZENA PLC Peptide CRO Services Product Offered
11.7.3 ABZENA PLC Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 ABZENA PLC Main Business Overview
11.7.5 ABZENA PLC Latest Developments
11.8 Buchi
11.8.1 Buchi Company Information
11.8.2 Buchi Peptide CRO Services Product Offered
11.8.3 Buchi Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Buchi Main Business Overview
11.8.5 Buchi Latest Developments
11.9 Aurigene Pharmaceutical Services
11.9.1 Aurigene Pharmaceutical Services Company Information
11.9.2 Aurigene Pharmaceutical Services Peptide CRO Services Product Offered
11.9.3 Aurigene Pharmaceutical Services Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Aurigene Pharmaceutical Services Main Business Overview
11.9.5 Aurigene Pharmaceutical Services Latest Developments
11.10 Syngene
11.10.1 Syngene Company Information
11.10.2 Syngene Peptide CRO Services Product Offered
11.10.3 Syngene Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Syngene Main Business Overview
11.10.5 Syngene Latest Developments
11.11 Cusabio
11.11.1 Cusabio Company Information
11.11.2 Cusabio Peptide CRO Services Product Offered
11.11.3 Cusabio Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Cusabio Main Business Overview
11.11.5 Cusabio Latest Developments
11.12 Immunocure
11.12.1 Immunocure Company Information
11.12.2 Immunocure Peptide CRO Services Product Offered
11.12.3 Immunocure Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Immunocure Main Business Overview
11.12.5 Immunocure Latest Developments
11.13 Thermo Fisher
11.13.1 Thermo Fisher Company Information
11.13.2 Thermo Fisher Peptide CRO Services Product Offered
11.13.3 Thermo Fisher Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Thermo Fisher Main Business Overview
11.13.5 Thermo Fisher Latest Developments
11.14 Svar Life Science
11.14.1 Svar Life Science Company Information
11.14.2 Svar Life Science Peptide CRO Services Product Offered
11.14.3 Svar Life Science Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Svar Life Science Main Business Overview
11.14.5 Svar Life Science Latest Developments
11.15 PolyPeptide
11.15.1 PolyPeptide Company Information
11.15.2 PolyPeptide Peptide CRO Services Product Offered
11.15.3 PolyPeptide Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 PolyPeptide Main Business Overview
11.15.5 PolyPeptide Latest Developments
11.16 JYMed Technology
11.16.1 JYMed Technology Company Information
11.16.2 JYMed Technology Peptide CRO Services Product Offered
11.16.3 JYMed Technology Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 JYMed Technology Main Business Overview
11.16.5 JYMed Technology Latest Developments
11.17 Peptites Biotech
11.17.1 Peptites Biotech Company Information
11.17.2 Peptites Biotech Peptide CRO Services Product Offered
11.17.3 Peptites Biotech Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Peptites Biotech Main Business Overview
11.17.5 Peptites Biotech Latest Developments
11.18 Sun-Novo Pharmaceutical Research
11.18.1 Sun-Novo Pharmaceutical Research Company Information
11.18.2 Sun-Novo Pharmaceutical Research Peptide CRO Services Product Offered
11.18.3 Sun-Novo Pharmaceutical Research Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Sun-Novo Pharmaceutical Research Main Business Overview
11.18.5 Sun-Novo Pharmaceutical Research Latest Developments
11.19 Genevoyager
11.19.1 Genevoyager Company Information
11.19.2 Genevoyager Peptide CRO Services Product Offered
11.19.3 Genevoyager Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Genevoyager Main Business Overview
11.19.5 Genevoyager Latest Developments
11.20 GenScript
11.20.1 GenScript Company Information
11.20.2 GenScript Peptide CRO Services Product Offered
11.20.3 GenScript Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 GenScript Main Business Overview
11.20.5 GenScript Latest Developments
11.21 Viva Biotech
11.21.1 Viva Biotech Company Information
11.21.2 Viva Biotech Peptide CRO Services Product Offered
11.21.3 Viva Biotech Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 Viva Biotech Main Business Overview
11.21.5 Viva Biotech Latest Developments
11.22 Space Peptides Pharmaceutical
11.22.1 Space Peptides Pharmaceutical Company Information
11.22.2 Space Peptides Pharmaceutical Peptide CRO Services Product Offered
11.22.3 Space Peptides Pharmaceutical Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.22.4 Space Peptides Pharmaceutical Main Business Overview
11.22.5 Space Peptides Pharmaceutical Latest Developments
11.23 TriApex Laboratories
11.23.1 TriApex Laboratories Company Information
11.23.2 TriApex Laboratories Peptide CRO Services Product Offered
11.23.3 TriApex Laboratories Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.23.4 TriApex Laboratories Main Business Overview
11.23.5 TriApex Laboratories Latest Developments
11.24 Go Top Peptide Biotech
11.24.1 Go Top Peptide Biotech Company Information
11.24.2 Go Top Peptide Biotech Peptide CRO Services Product Offered
11.24.3 Go Top Peptide Biotech Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.24.4 Go Top Peptide Biotech Main Business Overview
11.24.5 Go Top Peptide Biotech Latest Developments
11.25 IMED Bioscience
11.25.1 IMED Bioscience Company Information
11.25.2 IMED Bioscience Peptide CRO Services Product Offered
11.25.3 IMED Bioscience Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.25.4 IMED Bioscience Main Business Overview
11.25.5 IMED Bioscience Latest Developments
11.26 Motif Biotechnology
11.26.1 Motif Biotechnology Company Information
11.26.2 Motif Biotechnology Peptide CRO Services Product Offered
11.26.3 Motif Biotechnology Peptide CRO Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.26.4 Motif Biotechnology Main Business Overview
11.26.5 Motif Biotechnology Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
